A cancer diagnosis changes everything. In the hours and days that follow, patients often find themselves overwhelmed — navigating unfamiliar medical terminology, weighing complex treatment options, and managing intense emotional uncertainty. What makes a meaningful difference in outcomes and quality of life is not just the sophistication of available technology, but how care is organized, who coordinates it, and whether patients feel genuinely supported at every step. The oncology program developed by CHI St. Alexius Health is built around precisely this understanding: comprehensive, coordinated cancer care that accompanies patients from the moment of diagnosis through the conclusion of active treatment and well into survivorship.
St. Alexius Medical Center in Bismarck, North Dakota, has established itself as a regional anchor for advanced cancer care, serving patients from across the state and surrounding areas. Its oncology program integrates diagnostic precision, individualized treatment planning, multidisciplinary expertise, and robust patient support into a care model designed to reduce the total burden of cancer — medically, emotionally, and practically.
The Foundation: A Whole-Patient Philosophy
CHI St. Alexius approaches cancer not as a collection of isolated medical events, but as a continuous, evolving experience that demands sustained clinical attention and human support. From the first diagnostic finding to the final follow-up appointment, the oncology team at St. Alexius Medical Center works to ensure that no patient faces the process alone.
This philosophy shapes the structural design of the program. Rather than directing patients through disconnected departments, CHI St. Alexius brings multiple specialists together within a coordinated framework. Oncologists, radiologists, pathologists, surgeons, radiation therapists, oncology nurses, social workers, and patient navigators function as components of a unified team — an integrated model that evidence consistently links to improved clinical outcomes and higher patient satisfaction.
Step One: Accurate Diagnosis and Early Evaluation
The cancer care journey at St. Alexius Medical Center begins with a rigorous diagnostic process. Effective cancer treatment depends entirely on precision at this stage. Without a clear understanding of the tumor’s type, location, stage, and in many cases its molecular profile, even the most advanced therapies cannot be optimally targeted.
CHI St. Alexius provides access to a broad range of diagnostic tools. The following imaging and laboratory modalities are typically used depending on the cancer type under evaluation:
- CT (Computed Tomography) scans — used to detect tumors, assess their dimensions, and evaluate spread to nearby structures
- MRI (Magnetic Resonance Imaging) — delivers detailed imaging of soft tissue, particularly valuable for brain, spinal, and pelvic malignancies
- PET (Positron Emission Tomography) scans — identifies metabolically active cancer cells and assesses whether disease has spread to other regions of the body
- Ultrasound — commonly applied to evaluate thyroid, breast, and abdominal masses in real time
- Biopsy and pathology analysis — the definitive step in confirming diagnosis, classifying cell type, and detecting specific genetic mutations relevant to treatment selection
Together, these capabilities allow the oncology team at CHI St. Alexius to characterize each patient’s cancer in detail before any treatment decision is finalized. The specificity achieved at the diagnostic stage directly shapes the individualization of the treatment plan that follows.
Once a diagnosis is confirmed, patients meet with an oncologist who reviews all available findings and discusses the diagnosis in accessible terms. This consultation outlines the potential treatment path, addresses questions about clinical trial eligibility, and invites patients to express their preferences and concerns. The objective is to ensure that every individual enters treatment with a clear understanding of their situation and full awareness of the options in front of them.
Building the Treatment Plan: The Multidisciplinary Tumor Board
A defining feature of cancer care at St. Alexius Medical Center is the multidisciplinary tumor board — a regularly scheduled review meeting at which specialists from multiple disciplines examine complex cancer cases together. Medical oncologists, radiation oncologists, surgical oncologists, radiologists, and pathologists convene to assess diagnostic findings and collectively recommend a treatment approach.
This model matters because cancer treatment decisions are rarely simple. The optimal strategy for any given patient frequently depends on knowledge that spans several specialties at once. When a radiologist, a surgeon, and a medical oncologist review the same case together, the resulting plan reflects collective expert judgment rather than a single physician’s perspective working in isolation.
For patients, this process means that by the time a treatment plan is presented to them, it has already been reviewed by a panel of experienced specialists. The CHI St. Alexius tumor board process promotes consistency, precision, and genuine individualization across every oncology case it reviews.
Cancer Treatment Options at CHI St. Alexius
The treatment phase of cancer care typically involves one or more therapeutic approaches, selected based on the cancer type and stage, the patient’s overall health, and the goals of care. St. Alexius Medical Center offers the principal categories of treatment used in contemporary oncology.
Medical oncologists at CHI St. Alexius oversee systemic therapies — treatments that act throughout the body rather than at a single anatomical site. These include:
- Chemotherapy — cytotoxic drugs that destroy cancer cells or disrupt their ability to replicate
- Immunotherapy — agents that enhance the immune system’s capacity to identify and eliminate cancer cells
- Targeted therapy — drugs engineered to act on specific molecular targets found in particular cancer types
- Hormone therapy — used for cancers driven by hormonal signals, such as certain breast and prostate cancers
At St. Alexius Medical Center, systemic therapy selection is increasingly informed by molecular testing and genomic profiling. By identifying specific mutations or biomarkers, clinicians can predict how a cancer is likely to respond to a given drug — bringing precision medicine principles into routine oncology practice and improving treatment effectiveness from the outset.
Radiation Oncology
Radiation therapy uses high-energy beams to damage the DNA of cancer cells and prevent them from dividing. The radiation oncology program at CHI St. Alexius employs modern techniques designed to deliver precise radiation doses to tumors while protecting surrounding healthy tissue as much as possible. Depending on the clinical situation, radiation may serve as the primary treatment modality, be combined with surgery or systemic therapy, or be used in a palliative capacity to relieve symptoms caused by advanced disease.
Surgical Oncology
Surgery remains a primary treatment for many solid tumors. Surgical oncologists at St. Alexius Medical Center are trained in oncologic techniques that prioritize adequate cancer removal while preserving function and quality of life. Minimally invasive approaches — including laparoscopic and robotic-assisted procedures — are employed where appropriate to minimize surgical trauma, reduce recovery time, and limit postoperative complications.
How Treatment Modalities Work Together
The table below illustrates how different treatment approaches are commonly combined at St. Alexius Medical Center, depending on cancer type and stage. It reflects the multimodal philosophy that characterizes the CHI St. Alexius oncology program.
| Cancer Type | Common Primary Treatment | Common Adjuvant Treatment | Primary Goal |
|---|---|---|---|
| Early-stage breast cancer | Surgery (lumpectomy or mastectomy) | Radiation, hormone therapy, or chemotherapy | Curative |
| Locally advanced lung cancer | Concurrent chemotherapy and radiation | Immunotherapy (maintenance) | Curative or long-term control |
| Resectable colorectal cancer | Surgery | Adjuvant chemotherapy | Curative |
| Localized prostate cancer | Surgery or radiation | Hormone therapy (high-risk cases) | Curative |
| Metastatic (advanced) cancer | Systemic therapy | Palliative radiation, symptom management | Disease control and quality of life |
As the table demonstrates, cancer treatment at CHI St. Alexius is almost never a single-modality decision. The sequence and combination of therapies are carefully tailored to each patient’s specific cancer characteristics and individual circumstances, reinforcing why multidisciplinary collaboration is so central to this program.
Patient Navigation: Coordination That Removes Barriers
Among the most impactful elements of the cancer program at St. Alexius Medical Center is its patient navigation support. A new cancer diagnosis generates immediate logistical complexity — overlapping appointments, referrals across departments, insurance questions, and the need to communicate with family and employers — all at a time when emotional reserves are already stretched thin. Without structured guidance, that complexity can delay care or cause patients to disengage from treatment entirely.
Patient navigators at CHI St. Alexius act as dedicated points of contact who help individuals move through the system smoothly and with confidence. Their responsibilities commonly include:
- Coordinating appointments across multiple specialists and departments to minimize gaps and redundancy
- Translating treatment plans into plain, understandable language for patients and families
- Connecting patients with financial assistance programs and insurance support resources
- Identifying transportation, lodging, or home support needs — especially for patients traveling from rural or remote communities
- Providing emotional encouragement and referrals to counseling services or peer support groups
- Following up after appointments to confirm understanding and ensure continuity of care
For patients across North Dakota and the broader region served by St. Alexius Medical Center, this navigation function is not merely a convenience — it is often the difference between receiving timely, complete care and falling through the gaps of a complex healthcare system.
Supportive Care: Treating the Whole Person
Cancer treatment is effective, but it is also demanding. Chemotherapy, radiation, and surgery each carry potential side effects that affect daily life, energy levels, and overall wellbeing. Managing these challenges proactively is integral to the CHI St. Alexius approach — supportive care is incorporated throughout the treatment process, not introduced only when problems arise.
The following supportive care services are available to cancer patients at St. Alexius Medical Center to help them sustain health and function during treatment:
- Nutritional counseling — adequate nutrition during treatment supports immune function, energy, and the body’s capacity to tolerate and recover from therapy
- Pain management — a structured, individualized approach to managing cancer-related pain, whether caused by the disease itself or by treatment side effects
- Physical therapy and rehabilitation — particularly valuable after surgical procedures and for patients experiencing treatment-related fatigue or functional decline
- Mental health and behavioral health services — anxiety, depression, and cancer-related psychological distress are common and are most effectively addressed through proactive counseling or psychiatric support
- Social work services — addressing practical concerns such as financial stress, housing stability, and family support that directly affect a patient’s ability to engage with and complete treatment
By attending to these dimensions of a patient’s experience, CHI St. Alexius helps individuals maintain the physical and emotional reserves they need to complete their prescribed treatment and achieve the best possible outcomes.
Palliative Care: Comfort as a Clinical Priority
A persistent misconception about palliative care is that it signals the withdrawal of active treatment or the abandonment of curative intent. In reality, palliative care is a specialized layer of support focused on symptom management and quality of life — one that can be integrated at any point in the cancer journey, including during aggressive curative therapy.
St. Alexius Medical Center treats palliative care as a concurrent component of oncology, not a final resort. A patient undergoing concurrent chemotherapy and radiation, for example, may be contending with significant fatigue, nausea, pain, or respiratory symptoms. Palliative care specialists can address these issues in ways that allow the primary treatment to continue with reduced suffering and better tolerability.
The CHI St. Alexius palliative care team works alongside the oncology team — not in place of it. This integrated approach is consistent with growing clinical evidence suggesting that early palliative care involvement can improve survival in certain cancer populations, likely because patients are better supported and better able to complete their prescribed treatment courses.
Survivorship: Continuing Care After Treatment Ends
Completing active cancer treatment is a major milestone — but it is not the end of the care relationship. Many patients experience ongoing physical and emotional challenges in the weeks, months, and years that follow. Long-term side effects from therapy, fear of recurrence, difficulty returning to work, and the psychological adjustment to life after cancer are all well-documented and deserve structured attention.
CHI St. Alexius addresses this transition through survivorship programming that provides continued clinical oversight and personalized resources for patients who have completed treatment. Key components of survivorship care at St. Alexius Medical Center typically include:
- Individualized survivorship care plans — detailed documents summarizing the patient’s diagnosis, all treatments received, and a recommended schedule for ongoing monitoring
- Surveillance for recurrence — regular imaging and laboratory testing calibrated to the specific cancer type and the treatments the patient received
- Management of long-term treatment effects — including neuropathy, lymphedema, cardiovascular changes, and hormonal shifts that may persist well after therapy concludes
- Health promotion and lifestyle counseling — evidence-based guidance on diet, physical activity, and other factors that influence recurrence risk and overall long-term health
- Psychosocial support and peer connection — ongoing access to mental health resources, community support groups, and programs that help survivors rebuild confidence and routine
These survivorship services affirm that cancer care does not end with the last infusion or the final radiation session. The post-treatment period carries its own clinical and human complexity — and the CHI St. Alexius program is
structured to meet patients where they are during that chapter as well.
Conclusion: A Care Model Built Around Every Patient
What defines the oncology program at CHI St. Alexius is not any single treatment modality or piece of technology, but the architecture of coordinated, continuous care surrounding each patient at every stage of their journey. From the tumor board review and diagnostic workup to the final survivorship appointment, St. Alexius Medical Center organizes its cancer care around a consistent conviction: that truly effective oncology demands medical expertise, structural coordination, and compassionate support working together.
For individuals and families facing a cancer diagnosis in North Dakota and the broader region, the resources and clinical depth available through the CHI St. Alexius cancer program represent a meaningful foundation for navigating what is, by any measure, one of life’s most challenging experiences. Understanding how that care is organized — and what to expect at each stage — is itself a step toward engaging with it more effectively and with greater confidence.